Clinical Trial Update: Effect of GABA Supplementation in the Progression of Type 1 Diabetes in Children [Phase 2]

View source ↗

Summary

A Phase 2 trial assessing gamma-aminobutyric acid (GABA) supplementation for progression of Type 1 diabetes in children has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• GABA (gamma-aminobutyric acid)

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Diabetes Mellitus | Phase 2 | Status: WITHDRAWN